Mammography Systems Market Size & Share 2026-2035

Mammography Systems Market Size

The global mammography systems market was estimated at USD 3.6 billion in 2025. The market is expected to grow from USD 3.9 billion in 2026 to USD 7.5 billion in 2035, at a CAGR of 7.5% during the forecast period, according to the latest report published by Global Market Insights Inc.

The market is driven by numerous factors, such as increasing incidence of breast cancer across the globe, rising awareness about breast cancer screening and early detection, among other factors.

Mammography systems are specialized medical imaging devices used to capture high-resolution X-ray images of the breast for the early detection, diagnosis, and monitoring of breast abnormalities, including breast cancer. These systems play a critical role in routine screening programs by enabling the identification of tumors and microcalcifications at an early stage, often before symptoms become apparent. Advanced mammography technologies, such as digital mammography and breast tomosynthesis, further enhance diagnostic accuracy and support timely clinical intervention.

Rising government funding for breast cancer screening tests in developed countries is expected to fuel the industry's growth. Hologic, GE HealthCare, Siemens Healthineers, Philips, and Fujifilm are among the leading players operating in the market. These players maintain their market leadership through continuous investments in digital breast tomosynthesis (3D mammography), AI-powered image analysis, workflow automation, and expansion of breast imaging portfolios, while leveraging strong installed bases, global distribution networks, and long-standing partnerships with screening programs and healthcare providers.

The market has increased from USD 2.9 billion in 2022 and reached USD 3.4 billion in 2024, with a historic growth rate of 7.9%. Increasing incidence of breast cancer across the globe is a key factor driving the growth of the market, as rising disease burden continues to strengthen the need for early detection and routine screening programs. According to the World Health Organization (WHO), breast cancer remains the most common cancer among women globally, with approximately 2.3 million new cases and 670,000 deaths reported in 2022. Additionally, the International Agency for Research on Cancer (IARC) reported in 2025 that 1 in 20 women worldwide is expected to be diagnosed with breast cancer during her lifetime, and annual cases are projected to increase to 3.2 million by 2050 if current trends persist. This growing prevalence is encouraging governments and healthcare providers to expand breast cancer screening initiatives, thereby increasing the adoption of advanced mammography systems across both developed and emerging healthcare markets.

Additionally, rising awareness about breast cancer screening and early detection in developed countries is significantly contributing to the growth of the market. Government-led screening programs, public health campaigns, and clinical recommendations have increased participation in routine mammography screening, enabling earlier diagnosis and improved treatment outcomes. According to the U.S. Centers for Disease Control and Prevention (CDC), approximately 76.5% of women aged 50–74 years reported having a mammogram within the past two years as of the latest national survey data. Similarly, the European Commission reports that organized breast cancer screening programs are implemented across most EU member states, with several countries achieving participation rates exceeding 70% among the target population. The continued emphasis on preventive healthcare and early cancer detection is driving demand for advanced mammography technologies, including digital mammography and breast tomosynthesis systems.

Mammography Systems Market Trends

The continuous advancement of mammography technologies is playing a pivotal role in driving the growth of the market by improving breast cancer detection accuracy, enhancing workflow efficiency, and supporting personalized screening approaches.

• Digital breast tomosynthesis (DBT), commonly referred to as 3D mammography, is increasingly replacing conventional 2D mammography due to its ability to generate multiple low-dose images of the breast from different angles, creating a three-dimensional reconstruction. This technology improves lesion visualization, particularly in women with dense breast tissue, reduces tissue overlap, and enhances cancer detection rates while lowering recall rates for unnecessary follow-up examinations.
• The integration of artificial intelligence (AI) and computer-aided detection (CAD) algorithms is transforming breast imaging workflows by assisting radiologists in identifying suspicious abnormalities, prioritizing high-risk cases, and reducing interpretation variability. AI-powered solutions are being increasingly adopted to improve diagnostic confidence, streamline image analysis, and address growing radiology workforce shortages while supporting large-scale breast cancer screening programs.
• The market is also witnessing growing adoption of contrast-enhanced mammography (CEM) and advanced imaging software that provide functional as well as anatomical information about breast lesions. These technologies improve the characterization of suspicious findings and offer a cost-effective alternative to breast MRI in selected clinical settings, thereby supporting more accurate diagnosis and treatment planning.
• For instance, Hologic's 3Dimensions mammography system combines advanced digital breast tomosynthesis with intelligent imaging technologies designed to improve cancer detection and patient comfort while reducing callback rates. Additionally, Siemens Healthineers' Mammomat B. brilliant integrates contrast-enhanced mammography capabilities with advanced image processing to support improved visualization of breast lesions, particularly in dense breast tissue.
• Collectively, these technological advancements demonstrate the industry's strong focus on improving diagnostic accuracy, enhancing patient experience, and optimizing clinical workflows. As healthcare providers increasingly prioritize early breast cancer detection and precision diagnostics, continued innovation in mammography systems is expected to remain a key factor supporting the sustained growth of the market.

Mammography Systems Market Analysis

Based on the product, the mammography systems market is segmented into analog systems, full field digital mammography systems, and breast tomosynthesis systems. The full field digital mammography systems segment accounted for a dominant market share of 65.4% in 2025, driven by its well-established superiority over conventional film-based systems in terms of image quality, diagnostic accuracy, and workflow. The segment is expected to reach USD 4.7 billion by 2035, growing at a CAGR of 7% during the forecast period.

• Full field digital mammography systems dominate the market due to superior image quality, ease of storage, and seamless integration with digital workflows. The widespread replacement of older analog units with full-field digital mammography (FFDM) systems, driven by regulatory mandates, institutional procurement upgrades, and the growing demand for computer-aided detection capabilities, has been a key structural factor cementing this segment's leadership position across both developed and emerging healthcare markets.
• The segment's sustained dominance is further reinforced by the increasing integration of artificial intelligence into digital mammography platforms, which has significantly improved lesion detection accuracy and reduced radiologist workload. Favorable reimbursement frameworks in different regions, combined with the growing number of dedicated digital mammography centers being established, continue to drive high and consistent adoption volumes, reinforcing the segment's commercial leadership through the forecast period.
• The breast tomosynthesis systems segment is projected to expand at the fastest CAGR of 8.7% to reach USD 2.6 billion by 2035, driven by their demonstrably superior diagnostic performance compared to conventional 2D digital mammography, particularly in patients with dense breast tissue. Tomosynthesis utilizes high-resolution limited-angle tomography and X-rays to produce a three-dimensional image of the breast, improving early detection of breast cancer, enhancing cancer detection capabilities, and reducing false-positive results and the need for unnecessary biopsies. The growing clinical body of evidence supporting tomosynthesis as a more effective screening modality, combined with expanding reimbursement coverage for 3D mammography procedures in key markets, is accelerating the migration of healthcare facilities from 2D to 3D-capable systems.
• The analog systems segment is projected to expand at 4% CAGR to reach USD 170.1 million by 2035. The widespread adoption of digital and tomosynthesis-based alternatives has progressively eroded demand for conventional film-screen systems across developed markets. The segment retains a residual presence primarily in low- and middle-income countries, where the significantly lower acquisition and operational costs of analog systems continue to make them a pragmatic choice for healthcare facilities with constrained capital budgets and limited digital infrastructure.

Based on technology, the mammography systems market is segmented into screen film, 2D mammography, 3D mammography, contrast-enhanced mammography, and other technologies. The 2D mammography segment is projected to expand at 7.2% CAGR to reach USD 3.8 billion by 2035.

• 2D digital mammography holds the largest share in the market, driven by its well-established clinical role as the standard-of-care modality for routine breast cancer screening across both developed and emerging markets. The significantly lower acquisition cost of 2D systems compared to tomosynthesis platforms, combined with a large global installed base and physician familiarity built over decades of clinical use, has entrenched 2D digital mammography as the default technology choice across a broad range of healthcare settings.
• The segment's dominance is further sustained by continuous technological improvements within the 2D space itself, including advanced detector sensitivity, AI-assisted image analysis tools, and lower radiation dose protocols, which have extended the clinical relevance of 2D systems and deferred the urgency for facility-wide upgrades to 3D platforms. The requirement for accurate and rapid diagnostic reports, combined with the rapid adoption of 2D mammography devices across hospitals and diagnostic centers globally, continues to promote the growth of this segment.
• The 3D mammography segment is projected to expand at 7.6% CAGR to reach USD 2.9 billion by 2035. It is a fast-growing technology segment in the mammography market, propelled by its clinically proven ability to detect up to 20–65% more invasive breast cancers compared to conventional 2D mammography, particularly in women with dense breast tissue. It utilizes high-resolution limited-angle tomography to produce three-dimensional breast images, reducing false-positive results and the need for unnecessary repeat imaging.
• The mammography systems market from contrast-enhanced mammography segment is projected to expand at the fastest CAGR of 8.2% to reach USD 399.5 million by 2035 as it combines the benefits of digital mammography with intravenously administered iodinated contrast agents using a dual-energy technique, offering greater sensitivity than full-field digital mammography alone and FFDM combined with ultrasound, making it a compelling choice in the diagnostic setting for more accurate cancer characterization. In October 2023, Hologic and Bayer announced a collaborative effort to advance CEM adoption across Asia Pacific, Canada, and Europe, with the technique's ability to selectively highlight tumor vascularity through high-energy X-ray absorption of iodine significantly improving cancer detection accuracy.
• The screen film segment is projected to expand at 6.9% CAGR to reach USD 106.3 million by 2035. It represents the smallest segment, as widespread digitalization of breast imaging infrastructure has progressively displaced conventional film-based systems across most healthcare settings globally. The segment retains a residual presence primarily in low- and middle-income countries where the significantly lower cost of screen film systems continues to make them a practical option for facilities with constrained capital budgets and limited digital readiness.

Based on end use, the mammography systems market is segmented into hospitals, ambulatory surgical centers, and other end users. The hospitals segment is projected to expand at 7.5% CAGR to reach USD 4.5 billion by 2035.

• Hospitals hold the largest share in the global mammography systems, driven by their central role in delivering both screening and diagnostic mammography services within a single, comprehensive care setting. The presence of mammography facilities within hospitals positively influences several key aspects, including reduced hospital stay durations, lower overall healthcare costs, improved quality of care, and enhanced access to emergency medical services. The availability of multidisciplinary oncology teams, including radiologists, oncologists, and breast surgeons within hospital settings, enables seamless coordination of screening, diagnosis, and treatment, making hospitals the preferred institutional site for both routine screening and complex diagnostic mammography across developed and emerging markets.
• The segment's dominance is further reinforced by government and NGO-led national breast cancer screening programs, which are largely executed through hospital networks and drive consistent, high-volume procedural throughput. Hospitals also support large-scale deployments of advanced breast imaging equipment, particularly in urban healthcare systems, with their strong capital procurement capacity enabling the adoption of premium digital and tomosynthesis-based platforms as they become the new clinical standard.
• The ambulatory surgical centers segment is projected to expand at the highest CAGR of 8% to reach USD 2 billion by 2035, driven by the increasing shift of routine breast cancer screening toward lower-cost, high-efficiency outpatient settings as payers and healthcare systems prioritize cost containment. Diagnostic imaging centers are expanding rapidly as payers push routine screening into lower-cost outpatient settings, with ambulatory surgery centers increasingly investing in in-house imaging to bundle biopsy and lumpectomy services together, creating dedicated breast care pathways that improve patient retention and streamline the overall care journey. The increasing availability of compact, easy-to-operate mammography systems and AI-enabled imaging tools has made it practical for these centers to deliver high-quality breast screening without the need for large hospital infrastructure, further supporting their growing role in the mammography systems market.
• The other end users segment is projected to expand at a 6.7% CAGR to reach USD 932.1 million by 2035. The other end users segment includes diagnostic imaging centers, specialty clinics, and mobile screening units and is projected to grow at a moderate pace, supported by expanding access to breast cancer screening services. This segment plays a critical role in early detection initiatives, particularly in underserved and remote areas where hospital access may be limited. Mobile mammography units and independent diagnostic centers are increasingly being deployed to improve screening coverage and patient outreach.

 
North America Mammography Systems Market

The North America market accounted for a majority share of 34.8% in 2025 and is anticipated to show notable growth over the forecast period.

• The U.S. market was valued at USD 924.5 million and USD 993.5 million in 2022 and 2023, respectively. The market size reached USD 1.15 billion in 2025, growing from USD 1.07 billion in 2024, and is anticipated to grow at a CAGR of 7.1% from 2026 to 2035.
• North America holds the largest share in the market, driven primarily by the high and rising prevalence of breast cancer and the region's strong emphasis on early detection through organized, government-backed screening programs. According to the International Agency for Research on Cancer, an estimated 323,000 new breast cancer cases were diagnosed in North America in 2025, with projections rising to approximately 384,000 cases by 2045, underscoring the sustained and growing demand for mammography systems across the region.
• A key policy-level driver has been the U.S. Preventive Services Task Force's updated April 2024 guidelines, which recommended biennial mammography screening for all women aged 40 to 74; a significant policy shift that has meaningfully expanded the eligible screening population and reinforced clinical demand for mammography technologies across the U.S.
• The region's dominance is further supported by its well-established reimbursement framework, with Medicare and private insurers providing broad coverage for both 2D and 3D mammography procedures, making screening financially accessible to a large proportion of the female population. Digital systems now account for approximately 90% of all mammography procedures in the U.S., a transition supported by research demonstrating greater sensitivity of digital mammography, especially for younger women and those with dense breast tissue, while digital breast tomosynthesis has become increasingly common as studies indicate it detects more cancers than traditional 2D mammography while also lowering false positive rates.

Europe Mammography Systems Market

Europe accounted for a significant share of the market and was valued at USD 1 billion in 2025.

• Europe represents the second-largest regional market in the market, with growth primarily driven by a high and rising breast cancer burden across the region and the presence of well-organized, government-funded national screening programs that ensure consistent and high-volume procedural demand. Europe's Beating Cancer Plan aims to enhance screening efforts and ensure that by 2025, 90% of the eligible population will have access to mammography services, a landmark policy commitment that has significantly accelerated investments in screening infrastructure and device procurement across member states.
• The region's growth is further propelled by the rapid integration of AI and digital technologies into breast imaging workflows, with European healthcare systems increasingly adopting tomosynthesis and contrast-enhanced mammography as part of upgraded national screening protocols. In February 2025, the UK government launched a major AI trial involving nearly 700,000 participants across 30 sites to evaluate AI's effectiveness in improving early detection accuracy and efficiency in breast cancer screening, reflecting the region's strong policy commitment to technology-driven diagnostic improvement.
• The growing geriatric female population across Europe, with over 21.3% of the EU population aged 65 and above as of 2023, continues to expand the at-risk demographic requiring regular mammography screening, providing a sustained structural tailwind for market growth over the forecast period.

Asia Pacific Mammography Systems Market

The Asia Pacific market accounted for a substantial share of the market and was valued at USD 916.7 million in 2025.

• Breast cancer incidence is rapidly rising in Asia Pacific countries such as India, Taiwan, Singapore, China, and Japan, with improving healthcare infrastructure, favorable government initiatives, and rising awareness driving market growth across the region. Asian women are more likely to have heterogeneously or homogeneously dense breast tissue compared to Western populations, which can reduce the sensitivity of conventional screening methods. As a result, high-quality digital mammography systems become critically important for accurate early detection, strengthening the clinical need for advanced imaging technologies and driving upgrades in screening infrastructure across the region.
• The region's growth is further accelerated by rising disposable incomes, rapid urbanization, and the expansion of both public and private diagnostic facilities, which are collectively improving access to mammography services across both urban and semi-urban populations.

Latin America Mammography Systems Market

The Latin America market is anticipated to exhibit remarkable growth during the analysis period.

• Latin America represents a steadily growing regional market in the market, driven by a significant and rising breast cancer burden and increasing government commitment to early detection programs across key economies. According to the International Agency for Research on Cancer (IARC) under the World Health Organization, over 210,000 new breast cancer cases were reported in the region in 2020, representing nearly 15% of the global burden. Additionally, breast cancer accounts for approximately 25% of all cancer diagnoses among women in Latin America, highlighting its significant prevalence. These figures have driven strong policy momentum toward improving screening infrastructure, particularly by expanding access to mammography services across the region.
• Brazil and Mexico are the region's largest and most active markets, with Brazil's Unified Health System funding free mammography services for women and Mexico's Ministry of Health implementing national screening programs offering subsidized mammograms for women aged 40 and above, both of which are directly driving consistent device procurement and utilization volumes across the region.

Middle East and Africa Mammography Systems Market

The Middle East and Africa market is expected to experience substantial growth over the analysis timeframe.

• The Middle East & Africa represents the smallest but steadily growing regional market in the market, with growth driven by a combination of a rapidly worsening breast cancer burden, accelerating healthcare modernization, and expanding government-led screening mandates across key economies.
• Investments in healthcare modernization and the establishment of specialized diagnostic centers are improving access to screening services, while public health campaigns are promoting routine mammography screening among women. Although the market faces challenges such as limited access in rural areas and cost constraints, ongoing improvements in healthcare delivery systems and the introduction of cost-effective imaging solutions are expected to support continued market expansion across the MEA region.

Mammography Systems Market Share

• The mammography systems industry is highly dynamic, with key players such as Hologic, GE HealthCare, Siemens Healthineers, Philips, and Fujifilm, which collectively account for a 42.5% share of the global market.

• These players are actively expanding their breast imaging portfolios and geographic reach through product launches, strategic partnerships, and investments in digital health technologies. These initiatives enable manufacturers to enhance screening accuracy, improve workflow efficiency, and strengthen their presence across both developed and emerging healthcare markets.
• For instance, Hologic continues to reinforce its leadership in breast health through ongoing investments in R&D and breast imaging technologies, while GE HealthCare has collaborated with AI developers to integrate intelligent decision-support tools into its imaging ecosystem. Similarly, Siemens Healthineers has focused on expanding its digital and AI-enabled imaging capabilities through strategic partnerships and software innovations aimed at improving diagnostic accuracy and workflow efficiency.
• Furthermore, market participants are increasingly aligning their strategies with evolving healthcare priorities, including personalized cancer screening, workflow automation, and population-based breast cancer screening programs. The growing integration of artificial intelligence, cloud-based image management, and advanced analytics into mammography systems is enabling more efficient diagnosis and supporting value-based healthcare delivery. In addition, manufacturers are focusing on improving patient comfort, reducing radiation exposure, and enhancing accessibility to breast imaging services.
• Collectively, these strategic initiatives undertaken by leading market participants are shaping the competitive landscape, accelerating the adoption of advanced mammography technologies, and supporting the long-term growth of the market.

Mammography Systems Market Companies

A few of the prominent players operating in the mammography systems industry include:

• Analogic
• Canon Medical
• Carestream Health
• Delphinus Medical Technologies
• Fujifilm
• GE HealthCare
• Hologic
• IMS Giotto
• Konica Minolta
• Neusoft Medical Systems
• NP JSC Amico
• Philips
• Planmed
• Siemens Healthineers
• United Imaging Healthcare
• Hologic

Hologic maintains a leading position in the market through its strong specialization in breast health and extensive portfolio of breast imaging solutions. The company benefits from the widespread adoption of its 3Dimensions digital breast tomosynthesis (DBT) platform, strong clinical evidence supporting improved cancer detection, and a well-established presence across breast cancer screening programs globally. Its continuous investments in AI-enabled breast imaging and workflow optimization further strengthen its competitive advantage.

• GE healthcare

GE HealthCare is a key market participant owing to its broad imaging portfolio, global distribution network, and focus on patient-centric breast imaging solutions. The company's Senographe Pristina mammography platform has gained significant market acceptance due to its emphasis on patient comfort, operational efficiency, and integration with advanced digital technologies. Additionally, GE HealthCare's investments in AI-powered diagnostic tools and enterprise imaging solutions enable healthcare providers to improve screening efficiency and clinical outcomes.

• Siemens Healthineers

Siemens Healthineers maintains a strong market position through its expertise in advanced diagnostic imaging and digital healthcare technologies. The company differentiates itself through innovations in contrast-enhanced mammography, AI-driven image processing, and integrated imaging workflows, which support improved lesion visualization and diagnostic confidence. Its extensive global footprint, strong research capabilities, and focus on precision medicine continue to reinforce its leadership in the market.

Mammography Systems Industry News:

• In April 2024, Hologic signed a definitive agreement to acquire Endomag, a UK-based developer of breast cancer surgery localization and lymphatic tracing technologies, for approximately USD 310 million. The acquisition expanded Hologic's breast health portfolio beyond mammography into breast cancer surgery solutions, strengthening its position across the breast care continuum and enhancing its ability to offer integrated breast health technologies.
• In November 2024, GE HealthCare entered a strategic collaboration with RadNet's DeepHealth to accelerate the adoption of AI-powered imaging solutions. The partnership initially focused on integrating DeepHealth's SmartMammo breast imaging AI technology with GE HealthCare's mammography ecosystem, aiming to improve screening workflows, diagnostic accuracy, and operational efficiency in breast imaging.

The mammography systems market research report includes an in-depth coverage of the industry with estimates and forecasts in terms of revenue in (USD Million) from 2022 - 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Analog systems
• Full field digital mammography systems
• Breast tomosynthesis systems

Market, By Technology

• Screen film
• 2D mammography
• 3D mammography
• Contrast-enhanced mammography 
• Other technologies   

Market, By End Use

• Hospitals
• Ambulatory surgical centres
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE